HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxidative damage in ischemic stroke revealed using multiple biomarkers.

AbstractBACKGROUND AND PURPOSE:
We investigated changes in oxidative damage after ischemic stroke using multiple biomarkers.
METHODS:
Serial blood and urine samples of ischemic stroke subjects and age-matched control subjects were assayed for F₂-isoprostanes, hydroxyeicosatetraenoic acid products, F₄-neuroprostanes, 24-hydroxycholesterol, allantoin, and urate.
RESULTS:
Sixty-six stroke subjects (mean age, 65 years; median National Institutes of Health Stroke Scale 17) and 132 control subjects were recruited. A bimodal pattern of change was observed in plasma and urinary F₂-isoprostanes and plasma 24-hydroxycholesterol. The rise in plasma hydroxyeicosatetraenoic acid products, F₄-neuroprostanes, and allantoin was highest 6 to 12 hours after stroke onset, whereas plasma urate was significantly lower than controls on Days 1 to 3. After adjusting for age and baseline National Institutes of Health Stroke Scale, baseline plasma esterified hydroxyeicosatetraenoic acid products (OR, 1.01; 95% CI, 1.01 to 1.02), plasma urate (1.01; 1.00 to 1.01), and plasma free F₄-neuroprostanes (2.73; 1.76 to 3.93) were associated with 90-day good functional recovery (modified Rankin Scale ≤1).
CONCLUSIONS:
Multiple markers of oxidative damage are increased immediately after stroke and remain elevated for several days. Recognition of these temporal changes may help design better antioxidant treatment trials for acute ischemic stroke.
AuthorsRaymond C S Seet, Chung-Yung J Lee, Bernard P L Chan, Vijay K Sharma, Hock-Luen Teoh, Narayanaswamy Venketasubramanian, Erle C H Lim, Wan-Ling Chong, Woan-Foon Looi, Shan-Hong Huang, Benjamin K C Ong, Barry Halliwell
JournalStroke (Stroke) Vol. 42 Issue 8 Pg. 2326-9 (Aug 2011) ISSN: 1524-4628 [Electronic] United States
PMID21700941 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • F2-Isoprostanes
  • Hydroxycholesterols
  • Neuroprostanes
  • Allantoin
  • 24-hydroxycholesterol
Topics
  • Aged
  • Allantoin (metabolism)
  • Biomarkers (metabolism)
  • Brain Ischemia (metabolism)
  • F2-Isoprostanes (metabolism)
  • Female
  • Humans
  • Hydroxycholesterols (metabolism)
  • Male
  • Middle Aged
  • Neuroprostanes (metabolism)
  • Oxidation-Reduction
  • Oxidative Stress (physiology)
  • Stroke (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: